RAKESH CHANDRA: Open Payments
NPI 1225065220 · CARBONDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,743 in 73 payments from 12 companies in 2025. Trend: 2023 $362 · 2024 $165 · 2025 $1,743
Food & beverage: $1,743
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $478 |
| E.R. Squibb & Sons, L.L.C. | 20 | $444 |
| Janssen Pharmaceuticals, Inc | 5 | $211 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $162 |
| Alkermes, Inc. | 5 | $103 |
| Otsuka America Pharmaceutical, Inc. | 5 | $94 |
| Neurocrine BioSciences, Inc. | 4 | $74 |
| Braeburn Inc. | 3 | $70 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 2 | $37 |
Products named: VRAYLAR, COBENFY, SPRAVATO, CAPLYTA, ARISTADA, INGREZZA, BRIXADI, REXULTI.
Industry payments across IL — which companies pay providers there.
